Eylea Alternatives Compared
| Eylea Remove Eylea from your drug comparison | Lucentis Remove Lucentis from your drug comparison | Macugen Remove Macugen from your drug comparison |
|---|
| Eylea aflibercept Remove Eylea from your drug comparison | Lucentis ranibizumab Remove Lucentis from your drug comparison | Macugen pegaptanib Remove Macugen from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Macular Degeneration, Macular Edema, Diabetic Retinopathy, Diabetic Macular Edema. Eylea may also be used for purposes not listed in this medication guide. |
Prescribed for Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Myopic Choroidal Neovascularization, Macular Edema. Lucentis may also be used for purposes not listed in this... View more |
Prescribed for Macular Degeneration. Macugen may also be used for purposes not listed in this medication guide. |
||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
||||||||||||||||||
Drug Class |
||||||||||||||||||
Side Effects |
||||||||||||||||||
|
See the full Eylea side effects document. |
Common side effects include: cataract, increased intraocular pressure, intraocular inflammation. See the full Lucentis side effects document. |
See the full Macugen side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||
View all Eylea prices |
View all Lucentis prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Generic Availability |
||||||||||||||||||
|
No |
No |
No |
||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names |
||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||
|
144 hours |
216 hours |
336 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 1 drugs are known to interact with Lucentis:
|
A total of 2 drugs are known to interact with Macugen:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
||||||||||||||||||
First Approval Date |
||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
More Information |
||||||||||||||||||
Consumer Resources |
||||||||||||||||||
Professional Resources |
||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.